Those < 50 years of age who have IBD may receive the vaccine, and clinicians should engage in a shared decision-making discussion with patients to determine whether they should be vaccinated (see the Canadian Association of Gastroenterology's 2021 Clinical practice guideline for immunizations in patients with inflammatory bowel disease—Part 2: Inactivated vaccines).